Clomipramine in resistant obsessive compulsive disorder.

Area of Science:

• Psychiatry and Behavioral Sciences
• Clinical Pharmacology

Background:

• Obsessive Compulsive Disorder (OCD) is a debilitating mental health condition.
• Treatment resistance is a significant challenge in managing OCD.
• Existing treatments include pharmacotherapy (e.g., tricyclic antidepressants) and behavioral therapy.

Purpose of the Study:

• To evaluate the efficacy of clomipramine and nortriptyline in OCD patients unresponsive to other treatments.
• To investigate cross-resistance patterns in pharmacotherapy for OCD.

Main Methods:

• A crossover, double-blind trial was conducted.
• Twelve subjects with diagnosed OCD, non-responsive to amitriptyline and imipramine/behavior therapy, participated.
• Participants were treated with clomipramine and nortriptyline in a randomized sequence.

Main Results:

• Subjects who did not respond to prior treatments also did not respond to clomipramine.
• Nortriptyline's response in this cohort was not explicitly detailed but implied similar non-response based on the study's focus.

Conclusions:

• Clomipramine may not be effective for OCD patients with a history of non-response to other tricyclic antidepressants and behavioral therapy.
• Findings suggest potential cross-resistance or limited therapeutic options for treatment-refractory OCD.
• Further research is needed to explore alternative treatment strategies for this patient population.